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ABSTRACT
Objective: The objective of this study is to investigate the estrogenic and antiestrogenic activity of Fenugreek seeds, Trigonella foenum-graecum L. in 
the estrogen-dependent breast cancer cell line, MCF-7, including its effect on the expression of estrogen-dependent presenilin 2 (pS2) gene.
Methods: An activity guided fractionation was carried out with extracts from fenugreek seeds in MCF-7 cells. Cytotoxic activity assays were conducted 
with 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium (MTT) assay. Most fractions were also tested also tested in media with estradiol 10 nM We 
also analysed the expression of pS2 gene. For the analysis of pS2 gene expression we employed PCR primers for pS2 and for β-actin as a housekeeping 
gene using real-time polymerase chain reaction (RT-PCR).
Results: Based on cytotoxic activity assay in MCF-7, the active fractions are ethyl acetic fraction and its phases ethyl acetic (EA) 2 and EA 2.2. The 
most active fraction was EA 2.2 (IC50=27.129 ppm), which exhibited a biphasic effect; at low concentrations, it stimulated the growth, and at high 
concentrations it showed strong cytotoxic effects. EA2.2 fraction in concentration 20 ppm, also could induce pS2 gene expression in media with and 
without estrogen.
Conclusion: The most active fraction was the ethyl acetate phase and further subfractions. The most active fraction also induced the expression of 
pS2 gene which was studied by RT-PCR.
Keywords: Estrogenic effect, MCF-7, Presenilin 2 gene, Trigonella-foenum graecum L.
INTRODUCTION
Fenugreek seeds or Foenigraeci semen are the dried seeds from Trigonella 
foenum-graecum (TFG) L., Fabaceae [1,2]. Fenugreek seeds were assumed 
to have estrogen-like effects because they contain some steroids, for 
example, diosgenin, a precursor for sexual hormones [3], yamogenin [4], 
gitogenin, tigogenin, and trigoneoside (saponin-like estrogen) isomers [2]. 
Fenugreek seeds contain 0.8–2.2% diosgenin as aglycone [5]. In addition, 
fenugreek seeds also contain fatty oil 20–30%, alkaloids (trigonelline, 
an pyridine alkaloid, gentianin, and karpain), flavonoids, for example, 
vitexin in glycoside or ester form, isovitexin, orientin, vicenin, quercetin 
and luteolin [1], essential oil, nicotinamide, choline, and mucilage [3], and 
also galaktomannan [6]. Fenugreek seeds can induce uterine contractions; 
therefore, it should not be consumed during pregnancy [2].
Phytoestrogen is a compound in plants that exert estrogenic or 
antiestrogenic-like effects on animals and humans [7]. They bind weakly 
to estrogen receptor (ER) to induce transcription of estrogen-responsive 
target genes in a dose-dependent manner [8]. The relative affinities of 
phytoestrogens for ER are >102–105-fold lower than 17β-estradiol 
(E2), which is an important factor when considering dietary intake of 
phytoestrogens and their subsequent circulating concentrations [8]. 
Active phytoestrogens have been discovered among isoflavonoids, for 
example, genistein, biochanin A, and daidzein; coumestan, for example, 
coumestrol; stilbenes, for example, resveratrol; lignans, for example, 
enterolactone, matairesinol, and enterodiol; and steroidal sapogenin, 
for example, dammarane and diosgenin [9,10]. Phytoestrogens are 
being used as an alternative for hormone replacement therapy to help 
reducing the symptoms of menopause and premenstrual syndrome. It 
can be used in a long-term period until the body has adapted to the 
new hormone levels [11]. Nowadays, many phytoestrogens are being 
investigated as natural selective ER modulators (SERMs), specifically 
in the treatment of hormone-dependent breast cancers. Some 
phytoestrogens which are SERM without action on the uterus but with 
specific effects on the hypothalamus/pituitary complex and bones are 
presently the focus of clinical interest [12]. Phytoestrogens function as 
estrogen agonists in certain tissues but exhibit antiestrogenic effects 
in others [13]. According to Johnston, the ideal SERM should exhibit 
greater binding affinity for ER and have the ability to antagonize 
estrogen-dependent growth of breast cancer cells [14].
To date, few plant-derived SERMs have been evaluated in clinical 
trials, although a number of herbal remedies such as extracts of black 
cohosh and red clover are touted for the relief of postmenopausal 
and premenstrual symptoms [15]. The precise constituents of these 
extracts that might be responsible for such pharmacological effects are 
partly known, and isoflavonoids such as genistein have been reported 
to display both estrogenic and antiestrogenic effects [16]. Genistein is 
about 100-fold less potent than E2 in its ability to bind to ER, but its 
circulating concentrations in individuals consuming moderate amounts 
of soy foods are nearly 1000-fold higher than peak levels of endogenous 
E2 [17]. Interestingly, Asian women who consume a soy-rich diet have 
about a 6-fold lower risk of developing breast cancer than their western 
counterparts [18] and population-based studies have suggested that 
consumption of a phytoestrogen-rich diet is protective against prostate 
and bowel cancer, as well as cardiovascular disease [19]. Hence, it is 
possible that these phytoestrogens function as chemopreventive 
agents, and because human consumption of phytoestrogens is common, 
plant-derived agents are promising candidates for clinical trials [9].
© 2019 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
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In our previous study, we could show that fenugreek seed has 
estrogenic activity in rats [20]. The estrogenic activity of an ethanolic 
extract of fenugreek seeds was tested in two experimental models, that 
is, ovariectomized adult White female rats and immature rats (age of 
19 days). The extract had estrogenic effects on vaginal cornification, 
stimulated E2, and follicle-stimulating hormone (FSH) production of 
immature rats, decreased FSH level on ovariectomized rats, increased 
uterine, and mammary gland proliferation. This potency needs to 
be explored in more detail to find a phytoestrogen as an alternative 
treatment for hormonal disruption such as menopause. Besides, 
phytoestrogens are interesting candidates also for natural SERMs to 
treat breast cancer.
The present study investigated the cytotoxicity of some fractions 
of fenugreek seeds in the estrogen-dependent breast cancer cell 
line, MCF-7 in media with or without E2. This cell line allows the 
identification of estrogen agonist. Furthermore, the expression of an 
estrogen-dependent gene, presenilin 2 (pS2) will be monitored as a 
marker for agonistic and antagonistic ligands [21].
METHODS
Samples preparation
Fenugreek seeds were obtained from Tawangmangu, Central Java, 
Indonesia, and determinate by Research Centre for Biology, Indonesian 
Institute of Sciences, with document no. 252/IPH.1.02/If.8/2008. Seeds 
were dried and ground; then extracted with methanol. The methanolic 
extract was separated with n-hexane, ethyl acetic (EA), and n-butanol. 
Every phase was dried in a vacuum rotary evaporator. Each fraction then 
analyzed with 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
(MTT) assay on MCF7. The active fractions were separated using column 
chromatography with suitable eluents. Further separation followed the 
activity of the fraction (activity guided fractionation). Fractionation 
process can be seen in Fig. 1.
Cell culture
The cell line MCF-7 (human breast adenocarcinoma) was obtained 
from The Laboratory for Development of Agro Industry and Biomedical 
Technology (LAPTIAB-BPPT) Indonesia, and Department Biology, Institute 
of Pharmacy and Molecular Biotechnology (IPMB), Heidelberg University.
MCF-7 cells were routinely maintained and grown in 75 cm2 flasks 
at 37°C, 5% CO2 and in a 95% humidified atmosphere. The growth 
medium was prepared as follows: RPMI 1640, Gibco life Technologies 
with phenol red and 2 mM glutamine, 100 U/ml penicillin, 0.1 mg/ml 
streptomycin, 1 mM sodium pyruvate, and supplemented with 10% 
fetal bovine serum (FBS) (FBS, Gibco Life Technologies) that had been 
heat-inactivated at 56°C for 30 min. Passaging of cells was carried out 
using 4 ml of trypsin-ethylenediaminetetraacetic acid (EDTA) at room 
temperature for 3 min. Then, 10 ml media with 10% FBS were added to 
dilute trypsin in the cell culture. After centrifugation, the pelleted cells 
were distributed into new culture flasks.
Cytotoxicity test with MTT method
Cells were plated into 96-well plates (10,000 cells/well) in medium 
RPMI with phenol red containing 10 FBS, 100 U/ml penicillin, 0.1 mg/ml 
streptomycin, and 1 mM sodium pyruvate, then incubated for 24 h at 
37°C, 5% CO2, and in a 95% humidified atmosphere. After 24 h, samples 
(extracts and phases of TFG) were added to the growth medium in 
different concentration and incubated for another 24 h. Assays were 
done in a wide range of concentrations, from 10 ppm to 500 ppm.
After 24 h of treatment, cells were washed with phosphate buffer saline 
(PBS). Then, the MTT solution in the medium was added followed 
by incubation for 4 h. In living cells, crystals of formazan blue will be 
formed. The reaction was stopped by adding sodium dodecyl sulfate 
into every well. The plate was left in the dark for 12 h (overnight), and 
the intensity of the color formed was measured by an ELISA reader at 
570 nm.
Cell growth and proliferation in media with E2
Cells were plated into 96-well plates (30,000 cells/well) in an estrogen-
free culture medium with 10% stripped-FBS. Stripped FBS was prepared 
as follows; DCC solution consisted of 7.14 g of charcoal (Norit A), 714 mg 
of dextran T70, and 628 mg of NaCl dissolved in 50 ml H2O. 50 ml FBS 
were mixed with 1.5 ml DCC solution followed by centrifugation at 
×2100 g for 30 min. The supernatant was incubated with another 1.5 ml 
DCC solution for further 30 min at 37°C and centrifuged at ×210 g for 
another 30 min. The stripped serum was sterilized by filtering through 
a 0.22 μm filter and kept frozen at −20°C until use.
The cells were incubated for 48 h, and the medium was changed for 
every 24 h with or without test compounds and E2 (10 nM, as a positive 
control). After 48 h of treatment, the cells were washed twice with 
PBS. Neutral red (5 mg/100 ml in medium) was added, followed by 
incubation for 3 h at 37°C, 5% CO2, and in a 95% humidified atmosphere. 
Fig. 1: Fractionation followed by activity on MCF7 cells
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After incubation with neutral red, cells were washed twice with PBS. 
Subsequently, the dye is dissolved with 150 μl of HCl-isopropanol (0.04 
N HCl, 100% 2-propanol) and well homogenized on a plate shaker for 
30 min. Finally, the absorbance was measured with an ELISA reader at 
540 nm.
Cell growth for pS2 expression [22]
Cells were plated into 6 well plates (200,000 cells/well) in an estrogen-
free culture medium as described above. The medium was changed 
every 24 h with test compounds. After 48 h of treatment, the cells were 
washed twice with PBS. Cells were trypsinized using 300 μl/well of 
trypsin-EDTA at room temperature for 3 min. 2 ml medium (10% FBS) 
was added to dilute trypsin. Cells were centrifuged and pellets obtained 
were immediately used for RNA extraction.
Extraction and purification of RNA transcripts [22]
RNA was isolated with RNeasy Mini Kit (Qiagen), DNA was degraded with 
RNase-Free DNase set (Qiagen). RNeasy Mini Kit is a suitable system to 
isolate and clean total RNA from small quantities of cell material. This 
simple and fast method allows the isolation of up to 100 μg of total 
RNA from <107 cells. The isolation starts by loosening the pellets by 
flicking. A 350 μL standardized buffer RTL is added to the sample (10 μl 
β-mercaptoethanol [14.3 M] is added to 1.990 ml RTL buffer). The 
homogenization was done by passing the lysate 5 times through a gauge 
needle. An equal volume of 70% ethanol is added to the homogenized 
lysate and mixed well. The sample (700 μL) is applied onto the column 
and centrifuged >×8000 g for 15 s. The first wash step is performed by 
adding 350 μL buffer RW1 onto the column and centrifuged >×8000 g 
for 15 s. Residual DNA was digested by 80 μL of DNase I solution (10 μL 
2.72 Kunitz U/μL DNase) to 70 μL buffer RDD directly onto the column 
and incubated for 15 min at room temperature. After digestion, 350 μL 
buffer RW1 is added into the column and centrifuged >×8000 g for 
15 s. Washing steps were done twice by adding 500 μL buffer RPE and 
centrifuged >×8000 g for 15 s. To eluate, the adsorbed RNA from the 
column 30 μL of RNase-free water is added and centrifuged >×8000 g 
for 90 s. The obtained total RNA is immediately placed at −80°C.
The concentration of total RNA was estimated by absorption at 260 nm 
using NanoDrop Spectrophotometer (ND-1000 V3.30). To check the 
quality of total RNA electrophoresis on agarose gels (0.1% ethidium 
bromide) was carried out with 100V for 10 min.
Conversion of mRNA to complementary DNA (cDNA) [22]
mRNA was converted to cDNA, which is more stable to degradation 
and not attacked by ubiquitous RNAse. mRNA was reverse transcribed 
with Avian-Myeloblastosis-Virus reverse transcriptase (AMV-RTase) 
and kept at 20°C until real-time-polymerase chain reaction (RT-PCR) 
analysis. Protocol for reverse transcription: Step 1: PCR tube contains 
1 µg total RNA, 0.5 µg oligo (dT) and 5.6 µl diethyl pyrocarbonate-H2O; 
it was placed in RT-PCR 70°C for 5 min. Step 2: Then 1 mM dNTP, 15 
units reverse transcriptase (AMV-RTase), 20 units RNase inhibitor 
(RNasin®), and 5 mM MgCl2, 4 µl buffer ×5 (contains 10 mM Tris-HCl 
pH 7.0, 50 mM KCl, and 0.1% Triton® X-100) were add, then RT-PCR was 
carried out. cDNA obtained was stored at −20°C.
Analysis of the pS2 expression [22]
The primer for pS2 and β-actin as a housekeeping gene was obtained 
from eurofins-mwg-operon®.
The sequence for pS2 forward (f) and reverse (r) primers is:
pS2 (f) 5’- CAT GGA GAA CAA GGT GAT CTG -3’
pS2 (r) 5’- CAG AAG CGT GTC TGA GGT GTC-3’
The sequence for β-actin forward (f) and reverse (r) primers is:
β-actin (f) 5’-TCA TGA AGT GTG ACG TGG ACA TCC GC-3’
β-actin (r) 5’-CCT AGA AGC ATT TGC GGT GGA CGA TG-3’
RT-PCR conditions for both genes: Each PCR tube (20 µl) contained 1 µl 
cDNA, 200 µM dNTP, 400 nM pS2 or β-actin primers (f, r), PCR buffer 
(10 mM Tris-HCl 50 mM KCl, 1.5 mM MgCl2, 0.5% Triton X-100, and 
pH 8.5) and 1 U Taq DNA polymerase. PCR products were analyzed by 
agarose gel electrophoresis.
RESULTS AND DISCUSSION
Cell growth and proliferation study
Extracts were prepared from fenugreek seeds and subjected to activity 
guided fractionation. Results of corresponding cytotoxicity assays with 
MCF-7 are illustrated in Table 1.
The most active fraction was EA2.2 (IC50=27.129 ppm), which exhibited 
a biphasic effect; at low concentrations, it stimulated the growth, and at 
high concentrations it showed strong cytotoxic effects.
Cell growth of MCF 7 in medium with E2
To confirm the estrogen dependence of MCF-7 cells, they were grown 
for 24 h in a RPMI medium without phenol red, with 10% stripped-
FBS containing 10 nM ß-E2. Fig. 2 illustrates that E2 stimulated the 
proliferation of MCF-7 cells.
Fig. 2: Influence of different concentrations of estradiol on the 
growth of MCF-7 cells
Table 1: Cytotoxic activity IC50 (ppm) of some fractions of 
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This system was used to detect extracts and fractions which function as ER 
agonists. MCF-7 cells were treated 48 h with selected fractions in medium 
with or without 10 nM E2. Results in Fig. 3 show that at high dose, the 
extract from fenugreek seeds could inhibit the proliferation of MCF-7 cells. 
Both assays in medium with or without E2 10 nm gave the same pattern. 
Proliferation inhibition in media with E2 occurred at lower IC50 than in 
media without E2 (Table 2). Therefore, we assume that a competition of 
fenugreek seed fractions and E2 exists at the ER of MCF-7 cells.
According to Johnston, an ideal SERM, should exhibit greater binding 
affinity for ER and should, therefore, be able to antagonize estrogen-
dependent growth of breast cancer cells. The data in Table 2 show that the 
antiproliferative activity of some fenugreek fractions in media with E2 had 
been greater than in media without E2. From these data, we can conclude 
that fenugreek fraction EA2 has the ability to antagonize E2 in MCF-7 cells.
Analysis of pS2 expression
RT-PCR analysis was carried out to determine the relative copy number 
of pS2 and β-actin mRNA. PCR products were analyzed by agarose gel 
electrophoresis (Fig. 4). Presenilin-2 (pS2) is a protein that is expressed 
in estrogen-responsive cells after stimulation with E2 (Fig. 5).
The relative expression data show that pS2 was up-regulated in all 
cells treated with E2 and phytoestrogens in comparison to untreated 
controls by a mean factor of 1691 (S E range is 1357–2062).
EA2.2 fraction of Fenugreek seed (20 ppm) could induce pS2 gene 
expression in estrogen and estrogen-free medium (Fig. 6).
CONCLUSION
This study showed that the extracts from fenugreek seeds especially the 
ethyl acetic phase had cytotoxic effects in MCF-7 cells. Its IC50 in MCF-7 
grown in media with 10 nM E2 were lower than in media without E2. 
In addition to that, we also found that some fenugreek fractions could 
induce the expression of the estrogen-regulated gene, pS2, in MCF-7 
cell. From these data, we could conclude that Fenugreek seed can 
exhibit both estrogenic and antiestrogenic effects in MCF-7 cells.
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Fig. 3: (a-c) Effects of some fractions of fenugreek in the presence and absence of 10 nM estradiol on the growth of MCF-7
Fig. 4: Induction of presenilin 2 (pS2) expressions in MCF-7 cells. 
Polymerase chain reaction products of pS2 and β-actin were 
separated by agarose gel electrophoresis. M = medium with 
10% S-FBS, estradiol (E2)=10 nM E2, EA2.2=20 ppm fraction of 
fenugreek, EA2.2+=20 ppm fraction of fenugreek with presence 
of E2 10 nM
Fig. 5: Melting curves for presenilin 2 and β-actin
Table 2: Table of Inhibitory concentrations (IC50 [ppm]) of 
selected fractions in MCF-7 cells in the presence of 10 nM E2
Samples Without E2 With E2
IC50 (ppm) IC50 (ppm)
EtOAc fraction 244 119.9
EA2 fraction 1,751 714
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